Subscribe today!
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Infographics
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Infographics
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Subscribe!
Subscribe Today!
Home
/
Metabolic Disease
Metabolic Disease
| 5 min read
by
Stephanie DeMarco, PhD
A microbial signal from the gut promotes obesity
Gut microbes produce a metabolite that inhibits the conversion of fatty acids into energy and leads to weight gain in mice.
Articles
| 5 min read
by
Stephanie DeMarco, PhD
A new weight loss strategy turns fat into energy
By using extracellular vesicles to target specific neurons in the hypothalamus, scientists induced weight loss in a mouse model of obesity without altering its diet or exercise.
News
| 2 min read
by
DDNews Staff
Cholesterol may be key to new Alzheimer’s and diabetes therapies
University of Arizona researcher looks beyond traditional causes to find novel therapies
News
| 4 min read
by
Kristen Smith
Can a vaccine prevent type 1 diabetes?
Provention Bio advances work on coxsackievirus B vaccine
Articles
| 2 min read
by
DDNews Staff
Research highlights potential of Akero’s NASH candidate
Patients treated with efruxifermin show improvements in markers of insulin sensitivity and lipoprotein metabolism
Articles
| 3 min read
by
DDNews Staff
Albireo reports topline results from Phase 2 trial of elobixibat in NAFLD/NASH
Although primary endpoint was reached, the results were “unremarkable” and the company is discontinuing further development
Articles
Page 4 of 4 - 42 Total Items
1
2
3
4
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe
Sponsored
Explained: How are metabolite biomarkers improving drug discovery and development?
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Explainers
Latest Issue
Volume 21 • Issue 4 • December 2025
December 2025
December 2025 Issue
Explore this issue